|
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study |
|
|
|
Titel: |
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study |
Auteur: |
Bhushan B L, Shashi Wanve, Sunil Koradia, Parshottam Bhomia, Vinay Soni, Pravin Chakraborty, Sisir Khobragade, Akash Joshi, Shashank Mendiratta, Sanjeev Kumar Kansagra, Kevin Kumar Parihar, Anurag Sharma, Sunil Patel, Jatin |
Verschenen in: |
International journal of infectious diseases |
Paginering: |
Jaargang 111 () nr. C pagina's 281-287 |
Jaar: |
2021 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|